Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

February 2023; Volume 43,Issue 2

Reviews

  • Open Access
    The Latest Treatments for Cancer Cachexia: An Overview
    HAYATO WATANABE and TAKASHI OSHIMA
    Anticancer Research February 2023, 43 (2) 511-521; DOI: https://doi.org/10.21873/anticanres.16188
  • Open Access
    Intramedullary Spinal Cord Metastases from Breast Cancer: A Systematic Review
    GIANLUCA SCALIA, ROBERTA COSTANZO, ANNA VIOLA, LAPO BONOSI, MASSIMILIANO PORZIO, ANDREA GIOVANNINI, FRANCESCA GRAZIANO, DOMENICO GERARDO IACOPINO, ROSARIO MAUGERI, GIOVANNI FEDERICO NICOLETTI and GIUSEPPE EMMANUELE UMANA
    Anticancer Research February 2023, 43 (2) 523-535; DOI: https://doi.org/10.21873/anticanres.16189

Experimental Studies

  • Open Access
    Treatment of Human Pancreatic Cancers Following Local and Systemic Administration of Oncolytic Adenovirus Serotype 35
    RYOSUKE ONO, KOSUKE TAKAYAMA, RIKA ONISHI, SORA TOKUOKA, FUMINORI SAKURAI and HIROYUKI MIZUGUCHI
    Anticancer Research February 2023, 43 (2) 537-546; DOI: https://doi.org/10.21873/anticanres.16190
  • Open Access
    Hypoxia-adapted Multiple Myeloma Stem Cells Resist γδ-T-Cell-mediated Killing by Modulating the Mevalonate Pathway
    YUSUKE SANO, NAOKO KUWABARA, SAORI NAKAGAWA, YUKI TODA, SHIGEKUNI HOSOGI, SHINJI SATO and EISHI ASHIHARA
    Anticancer Research February 2023, 43 (2) 547-555; DOI: https://doi.org/10.21873/anticanres.16191
  • Open Access
    Contrast-enhanced Ultrasound Using Intradermal Microbubble Sulfur Hexafluoride for Identification of Sentinel Lymph Nodes During Breast Cancer Surgery: A Clinical Trial
    ORESTE CLAUDIO BUONOMO, MARCO MATERAZZO, MARCO PELLICCIARO, GIADA IAFRATE, BENEDETTO IELPO, STEFANO RIZZA, CHIARA ADRIANA PISTOLESE, TOMMASO PERRETTA, ROSARIA MEUCCI, BENEDETTO LONGO, VALERIO CERVELLI and GIANLUCA VANNI
    Anticancer Research February 2023, 43 (2) 557-567; DOI: https://doi.org/10.21873/anticanres.16192
  • You have access
    Itraconazole Repolarizes Tumor-associated Macrophages and Suppresses Cervical Cancer Cell Growth
    YUMI TAKIMOTO, HIROSHI TSUBAMOTO, ROZE TANIGUCHI, KAZUKO SAKATA, YOKO TAKADA, JUN ADACHI, TAKESHI TOMONAGA, TOMOKO UEDA, KOHEI NAKAGAWA, SACHIYO NARITA, YU WAKIMOTO and HIROAKI SHIBAHARA
    Anticancer Research February 2023, 43 (2) 569-580; DOI: https://doi.org/10.21873/anticanres.16193
  • Open Access
    Ultra-high Dose-rate Carbon-ion Scanning Beam With a Compact Medical Synchrotron Contributing to Further Development of FLASH Irradiation
    MASASHI YAGI, SHINICHI SHIMIZU, KAZUMASA MINAMI, NORIAKI HAMATANI, TOSHIRO TSUBOUCHI, MASAAKI TAKASHINA, MASUMI UMEZAWA, TAKUYA NOMURA, WATARU MUKOYOSHI, TEIJI NISHIO, MASAHIKO KOIZUMI, KAZUHIKO OGAWA and TATSUAKI KANAI
    Anticancer Research February 2023, 43 (2) 581-589; DOI: https://doi.org/10.21873/anticanres.16194
  • You have access
    Prognostic Value of WNT1, NOTCH1, PDGFRβ, and CXCR4 in Oral Squamous Cell Carcinoma
    PIOTR CIERPIKOWSKI, ANNA LIS-NAWARA and JULIA BAR
    Anticancer Research February 2023, 43 (2) 591-602; DOI: https://doi.org/10.21873/anticanres.16195
  • You have access
    Eribulin Treatment Promotes Re-expression of Estrogen Receptor in Endocrine Therapy-resistant Hormone Receptor-positive Breast Cancer Cells
    WATARU GOTO, SHINICHIRO KASHIWAGI, NOZOMI IIMORI, RIKA KOUHASHI, AKIMICHI YABUMOTO, KOJI TAKADA, YUKA ASANO, YUKIE TAUCHI, KANA OGISAWA, TAMAMI MORISAKI, MASATSUNE SHIBUTANI, HIROAKI TANAKA and KIYOSHI MAEDA
    Anticancer Research February 2023, 43 (2) 603-611; DOI: https://doi.org/10.21873/anticanres.16196
  • You have access
    Anti-VEGF and Anti-EGFR Antibody Therapy on T-Cell Infiltration and TCR Variation in Metastatic Colorectal Cancer
    MING XU, RYOUICHI TSUNEDOMI, KAZUMA KIYOTANI, SHINOBU TOMOCHIKA, KEI FURUYA, MASAO NAKAJIMA, HIROTO MATSUI, YUKIO TOKUMITSU, YOSHITARO SHINDO, SHIN YOSHIDA, MICHIHISA IIDA, NOBUAKI SUZUKI, SHIGERU TAKEDA, TATSUYA IOKA, SHOICHI HAZAMA and HIROAKI NAGANO
    Anticancer Research February 2023, 43 (2) 613-620; DOI: https://doi.org/10.21873/anticanres.16197
  • You have access
    Antitumor Effects of Deep Ultraviolet Irradiation for Pancreatic Cancer
    KIMITOSHI YAMAZAKI, TOSHIO KOKURYO, JUNPEI YAMAGUCHI, MASAKI SUNAGAWA, ATSUSHI OGURA, NOBUYUKI WATANABE, SHUNSUKE ONOE, KAZUSHI MIYATA, TAKASHI MIZUNO, KAY UEHARA, TSUYOSHI IGAMI, YUKIHIRO YOKOYAMA, TOMOKI EBATA and MASATO NAGINO
    Anticancer Research February 2023, 43 (2) 621-630; DOI: https://doi.org/10.21873/anticanres.16198
  • You have access
    Spontaneous Regression of Swine Melanoma: The Role of Tumour-infiltrating T and NK Cells
    DANIELA PLANSKA and VRATISLAV HORAK
    Anticancer Research February 2023, 43 (2) 631-638; DOI: https://doi.org/10.21873/anticanres.16199
  • You have access
    5-Azacytidine (5-aza) Induces p53-associated Cell Death Through Inhibition of DNA Methyltransferase Activity in Hep3B and HT-29 Cells
    DAE-YEON KIM, RANGYEON LEE, HEE-TAE CHEONG, CHANG-SIX RA, KI-JONG RHEE, JEONGHO PARK and BAE DONG JUNG
    Anticancer Research February 2023, 43 (2) 639-644; DOI: https://doi.org/10.21873/anticanres.16200
  • You have access
    Epithelial–Mesenchymal Transition Phenotype and Peritumoral Immune Cell Infiltration in Advanced Biliary Tract Cancer
    CHUNG RYUL OH, HYUNG-DON KIM, YEON-MI RYU, SEONMIN LEE, DANBEE KIM, DA SOL LEE, JAE HO JEONG, HEUNG-MOON CHANG, BAEK-YEOL RYOO, KYU-PYO KIM, MIYEON KIM, SANG-YEOB KIM and CHANGHOON YOO
    Anticancer Research February 2023, 43 (2) 645-652; DOI: https://doi.org/10.21873/anticanres.16201

Clinical Studies

  • Open Access
    Real-World Data on Olaparib in Relapsed BRCA-mutated Ovarian Cancer: A Multicenter GINECO RETROLA Cohort Study
    HELOÏSE BOURIEN, LEÏLA BENGRINE LEFEVRE, MARIE-ANGE MOURET-REYNIER, BERNARD ASSELAIN, BRIGITTE LUCAS, CELINE GAVOILLE, CORINA CORNILA, LAURENE GAVOILLE, EMELINE COLOMBA, ANNE PATSOURIS, MICHEL FABBRO, CAMILLE CHAKIBA, PHILIPPE TOUSSAINT, HELENE SIMON, DOMINIQUE BERTON, DELPHINE GARBAY, CLAIRE GARNIER TIXIDRE, DAVID COEFFIC, AURELIE MORVAN, OLIVIER COLLARD and THIBAULT DE LA MOTTE ROUGE
    Anticancer Research February 2023, 43 (2) 653-662; DOI: https://doi.org/10.21873/anticanres.16202
  • Open Access
    Risk of Neurological Decline in Patients With Temporal Lobe Brain Masses
    JARED SWEENEY, MELANIE BONDOC, SRUTI BANDLAMURI, MATT HOLDAWAY, POUYA ENTEZAMI, MICHAEL W. O’BRIEN and MATTHEW A. ADAMO
    Anticancer Research February 2023, 43 (2) 663-668; DOI: https://doi.org/10.21873/anticanres.16203
  • Open Access
    Refined Diagnosis of Pleural Effusions by Immunocytochemistry of Cell Blocks
    HIRSH KOYI and ERIK WILANDER
    Anticancer Research February 2023, 43 (2) 669-673; DOI: https://doi.org/10.21873/anticanres.16204
  • Open Access
    Comparison of the Efficacy and Toxicity of Concurrent Chemoradiotherapy and Durvalumab and Concurrent Chemoradiotherapy Alone for Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node Metastasis
    TAKANORI ABE, MISAKI IINO, SATOSHI SAITO, TOMOMI AOSHIKA, YASUHIRO RYUNO, TOMOHIRO OHTA, MITSUNOBU IGARI, RYUTA HIRAI, YU KUMAZAKI, YU MIURA, KYOICHI KAIRA, HIROSHI KAGAMU, SHIN-EI NODA and SHINGO KATO
    Anticancer Research February 2023, 43 (2) 675-682; DOI: https://doi.org/10.21873/anticanres.16205
  • Open Access
    Ki67 and E-cadherin Are Independent Predictors of Long-term Survival in Endometrial Carcinoma
    BELEN MARTIN-SALAMANCA, DIEGO ERASUN, JAVIER LLORCA and JOSE SCHNEIDER
    Anticancer Research February 2023, 43 (2) 683-687; DOI: https://doi.org/10.21873/anticanres.16206
  • Open Access
    Clinical Course of Vitamin B12 Deficiency and Associated Risk Factors in Patients After Total Gastrectomy for Gastric Cancer
    TORU AOYAMA, KENTARO HARA, YUKIO MAEZAWA, KEISUKE KAZAMA, ITARU HASHIMOTO, SHO SAWAZAKI, KEISUKE KOMORI, HIROSHI TAMAGAWA, AYAKO TAMAGAWA, KAZUKI KANO, HARUHIKO CHO, JUNYA MORITA, KENKI SEGAMI, MIE ISHIMOTO, TAKASHI OSHIMA, NORIO YUKAWA and YASUSHI RINO
    Anticancer Research February 2023, 43 (2) 689-694; DOI: https://doi.org/10.21873/anticanres.16207
  • You have access
    Preoperative Plasma miRNA Levels Predict Prognosis in Early-stage Malignant Melanoma
    MAHYAR SHARIF BAGHERI, JIRI POLIVKA, INKA TRESKOVA, KATERINA HOUFKOVA, TEREZA KNIZKOVA, VLASTIMIL WOZNICA, TOMAS FIKRLE, KRISTYNA PIVOVARCIKOVA, MARTIN SVATON, DATTATRYA SHETTI, RASHMI NEGI and MARTIN PESTA
    Anticancer Research February 2023, 43 (2) 695-706; DOI: https://doi.org/10.21873/anticanres.16208
  • You have access
    Evaluation of 95-Gene Classifier of Formalin-fixed Paraffin-embedded Tissues in ER-positive, HER2-negative, and Node-negative Breast Cancer
    HIROKO YAMASHITA, KANAKO C. HATANAKA, KEISUKE YAMAGISHI, YURIA SAITO, KENGO HAMASAKI, MITSURU TANIGUCHI, ASAMI OKUMURA, AYAE NANGE, YOSHIHIRO MATSUNO and YUTAKA HATANAKA
    Anticancer Research February 2023, 43 (2) 707-711; DOI: https://doi.org/10.21873/anticanres.16209
  • You have access
    Real-world Efficacy and Safety of Atezolizumab Plus Bevacizumab, Paclitaxel and Carboplatin for First-line Treatment of Japanese Patients With Metastatic Non-squamous Non-small Cell Lung Cancer
    NOBUMITSU IKEUCHI, FUMIYASU IGATA, ERIKO KINOSHITA, TOSHIAKI KAWABATA, IBUN TAN, YUSUKE OSAKI, RIKAKO OTSUKA, RINTARO ON, TAKATO IKEDA, AKIRA NAKAO, TOMOYA SASAKI, TAKASHI AOYAMA, RYOSUKE HIRANO, TAISHI HARADA, NORIYUKI EBI, MASAKI FUJITA and HIROYUKI INOUE
    Anticancer Research February 2023, 43 (2) 713-724; DOI: https://doi.org/10.21873/anticanres.16210
  • Open Access
    Relationship Between Osimertinib Concentration and Clinical Response in Japanese Patients With Non-small Cell Lung Cancer
    MIZUKI YAMAZAKI, NAO KOMIZO, HIROTOSHI IIHARA, CHIEMI HIROSE, KOMEI YANASE, YUTO YAMADA, JUNKI ENDO, SHUJI YAMASHITA, YASUSHI OHNO, KENICHIRO TODOROKI, AKIO SUZUKI and HIDEKI HAYASHI
    Anticancer Research February 2023, 43 (2) 725-732; DOI: https://doi.org/10.21873/anticanres.16211
  • You have access
    Breast Conserving Surgery in Combination With Targeted Intraoperative Radiotherapy Compared to Mastectomy for In-breast-tumor-recurrence
    HANS-CHRISTIAN KOLBERG, HELENA NIESING, JAYANT S. VAIDYA, LEYLA AKPOLAT-BASCI, ABDRHMAN MAGUZ, OLIVER HOFFMANN, GYOERGY LOEVEY, MILTIADES STEPHANOU and CORNELIA KOLBERG-LIEDTKE
    Anticancer Research February 2023, 43 (2) 733-739; DOI: https://doi.org/10.21873/anticanres.16212
  • You have access
    Independent Validation of a Risk Stratification Model Predicting Survival in Elderly Patients Irradiated for Bone Metastases
    CARSTEN NIEDER, LUKA STANISAVLJEVIC, BÅRD MANNSÅKER and ELLINOR C. HAUKLAND
    Anticancer Research February 2023, 43 (2) 741-747; DOI: https://doi.org/10.21873/anticanres.16213
  • You have access
    Prognostic Factors and Independent Validation of a Risk Stratification Model in Octogenarian Patients Irradiated for Brain Metastases
    CARSTEN NIEDER and ASTRID DALHAUG
    Anticancer Research February 2023, 43 (2) 749-753; DOI: https://doi.org/10.21873/anticanres.16214
  • You have access
    Lenvatinib Versus Sorafenib in Advanced Hepatic Cell Carcinoma: A Double Center Retrospective Analysis
    GIOVANNI ANTONIO MARROCCO, MARIANNA SILLETTA, VINCENZO BIANCO, FRANCESCO MONDERA, CAROLINA SCIORTINO, LAURA PAPPALARDO, VALENTINA VIGLIALORO, ENRICO CORTESI, GIUSEPPE TONINI and SALVATORE CAPONNETTO
    Anticancer Research February 2023, 43 (2) 755-763; DOI: https://doi.org/10.21873/anticanres.16215
  • You have access
    Pelvic Recurrence After Curative Resection for Rectal Adenocarcinoma: Impact of Surgery on Survival
    CECILIA FERRARI, LETIZIA CUNIOLO, MATTEO MASCHERINI, MATTEO SANTOLIQUIDO, STEFANO DI DOMENICO and FRANCO DE CIAN
    Anticancer Research February 2023, 43 (2) 765-771; DOI: https://doi.org/10.21873/anticanres.16216
  • You have access
    Breaking Bad News During the COVID-19 Pandemic: A Systematic Review of the Literature
    GEORGIOS GOUMAS, NIKOLAOS SYRIGOS, ELENI FYTA, THEODOROS I. DARDAVESIS and EFFIE SIMOU
    Anticancer Research February 2023, 43 (2) 773-779; DOI: https://doi.org/10.21873/anticanres.16217
  • You have access
    Correlation of Pre- and Post-radio-chemotherapy MRI Texture Features With Tumor Response in Rectal Cancer
    FABIOLA PAIAR, MICHELA GABELLONI, FRANCESCO PASQUALETTI, PAOLA COCUZZA, SABRINA MONTRONE, CHIARA ARENA, LORENZO FAGGIONI, ZENO FALASCHI, LORENZO DEL SECCO, ANGEL ALBERICH-BAYARRI, LUIS MARTI BONMATI and EMANUELE NERI
    Anticancer Research February 2023, 43 (2) 781-788; DOI: https://doi.org/10.21873/anticanres.16218
  • You have access
    Small Bowel Lipomatosis: An Unusual Radiological Finding in Patients With Renal Cell Cancer on Pazopanib
    ANAND SHARMA, AMISH LAKHANI, SUBHADIP GHOSH-RAY, SALMA ALAM, ANWAR PADHANI, ANDREW GOGBASHIAN and PAUL NATHAN
    Anticancer Research February 2023, 43 (2) 789-793; DOI: https://doi.org/10.21873/anticanres.16219
  • You have access
    Comparison of Two Cisplatin Regimens for Chemoradiation in Patients With Squamous-cell Carcinoma of the Head and Neck
    INGA ZWAAN, TAMER SOROR, KARL L. BRUCHHAGE, SAMER G. HAKIM, STEVEN E. SCHILD and DIRK RADES
    Anticancer Research February 2023, 43 (2) 795-800; DOI: https://doi.org/10.21873/anticanres.16220
  • You have access
    Comparison of Three Survival Scores in a Series of Patients ≥80 Years of Age Irradiated for Bone Metastases
    DIRK RADES, CANSU DELIKANLI, STEVEN E. SCHILD, CHARLOTTE KRISTIANSEN, SOREN TVILSTED and STEFAN JANSSEN
    Anticancer Research February 2023, 43 (2) 801-807; DOI: https://doi.org/10.21873/anticanres.16221
  • You have access
    Carbon Ion Radiotherapy Versus Perioperative Adjuvant Chemotherapy and Curative Surgery for Resectable Pancreatic Cancer
    NAOTO YAMAMOTO, TAKASHI OSHIMA, SHINNOSUKE KAWAHARA, DAISHI TAKAHASHI, YUTO KAMIOKA, MASAAKI MURAKAWA, HIROYUKI KATOH, MAKOTO UENO and SOICHIRO MORINAGA
    Anticancer Research February 2023, 43 (2) 809-815; DOI: https://doi.org/10.21873/anticanres.16222
  • You have access
    Comparing Survival Outcomes and Impact of EPIC in Patients Undergoing CRS/HIPEC for Mucinous Appendiceal Neoplasm
    MELANIE MERCADO, RAPHAEL SHAMAVONIAN, ERNEST CHENG, NIMA AHMADI and DAVID L. MORRIS
    Anticancer Research February 2023, 43 (2) 817-822; DOI: https://doi.org/10.21873/anticanres.16223
  • Open Access
    Evaluation of the Impact of Smoking and Alcohol Consumption on Toxicity and Outcomes of Chemoradiation for Head and Neck Cancer
    DIRK RADES, INGA ZWAAN, STEFAN JANSSEN, NATHAN Y. YU, STEVEN E. SCHILD, CHRISTIAN IDEL, RALPH PRIES, SAMER G. HAKIM and TAMER SOROR
    Anticancer Research February 2023, 43 (2) 823-830; DOI: https://doi.org/10.21873/anticanres.16224
  • You have access
    Chemerin and Chemokine-like Receptor 1 Are Not Prognostic in Colorectal Carcinoma
    FLORIAN WEBER, RUDOLF JUNG, OLIVER TREECK and CHRISTA BUECHLER
    Anticancer Research February 2023, 43 (2) 831-839; DOI: https://doi.org/10.21873/anticanres.16225
  • You have access
    Prognostic Value of Serum Soluble PD-L1 in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab
    NAOTO WAKITA, NOBUYUKI HINATA, YUKARI BANDO, TAKUTO HARA, TOMOAKI TERAKAWA, JUNYA FURUKAWA, YUZO NAKANO and MASATO FUJISAWA
    Anticancer Research February 2023, 43 (2) 841-847; DOI: https://doi.org/10.21873/anticanres.16226
  • You have access
    Prognostic Impact of Smoking on Bevacizumab Combination Chemotherapy for Advanced Breast Cancer
    KOJI TAKADA, SHINICHIRO KASHIWAGI, NOZOMI IIMORI, RIKA KOUHASHI, AKIMICHI YABUMOTO, WATARU GOTO, YUKA ASANO, YUKIE TAUCHI, KANA OGISAWA, TAMAMI MORISAKI, MASATSUNE SHIBUTANI, HIROAKI TANAKA and KIYOSHI MAEDA
    Anticancer Research February 2023, 43 (2) 849-856; DOI: https://doi.org/10.21873/anticanres.16227
  • You have access
    Clinical Relevance of Proximal Gastrectomy With Double-flap Esophagogastrostomy Reconstruction With Glycemic Profile and Postgastrectomy Syndromes
    JUN SHIBAMOTO, TAKESHI KUBOTA, KEIJI NISHIBEPPU, TAKUMA OHASHI, HIROTAKA KONISHI, ATSUSHI SHIOZAKI, HITOSHI FUJIWARA and EIGO OTSUJI
    Anticancer Research February 2023, 43 (2) 857-864; DOI: https://doi.org/10.21873/anticanres.16228
  • You have access
    Time to Pain Relapse After Palliative Radiotherapy for Bone Metastasis: A Prospective Multi-institutional Study
    ANNEYUKO I. SAITO, TAKAHISA HIRAI, TATSUYA INOUE, NOBORU HOJO, SATORU KAWAI, YUI KATO, KANA ITO, MASAKO KATO, YUKIKO OZAWA, HIDENORI SHINJO, KAZUMA TODA and RYO-ICHI YOSHIMURA
    Anticancer Research February 2023, 43 (2) 865-873; DOI: https://doi.org/10.21873/anticanres.16229
  • You have access
    Glasgow Prognostic Score Predicts Survival and Recurrence Pattern in Patients With Hepatocellular Carcinoma After Hepatectomy
    TAKAFUMI KUMAMOTO, KAZUHISA TAKEDA, RYUSEI MATSUYAMA, YU SAWADA, KOTA SAHARA, YASUHIRO YABUSHITA, YUKI HOMMA, JUN WATANABE, MASAKATSU NUMATA, TSUTOMU SATO, DAISUKE MORIOKA, CHIKARA KUNISAKI and ITARU ENDO
    Anticancer Research February 2023, 43 (2) 875-882; DOI: https://doi.org/10.21873/anticanres.16230
  • You have access
    Analysis of Clinical Factors in Olaparib-related Anemia Using Adverse Drug Event Reporting Databases
    CHIHIRO SHIRAISHI, TOSHINORI HIRAI, TORU OGURA and TAKUYA IWAMOTO
    Anticancer Research February 2023, 43 (2) 883-891; DOI: https://doi.org/10.21873/anticanres.16231
  • You have access
    Prognostic Significance of Preoperative Nutritional Assessment in Elderly Patients who Underwent Laparoscopic Gastrectomy for Stage I-III Gastric Cancer
    HIDEO UEHARA, MITSUHIKO OTA, MANABU YAMAMOTO, TOMONORI NAKANOKO, YUKI SHIN, KEIICHI SHIOKAWA, YOSHIAKI FUJIMOTO, YUICHIRO NAKASHIMA, MASAHIKO SUGIYAMA, EMI ONISHI, TOMONARI SHIMAGAKI, YOHEI MANO, KEISHI SUGIMACHI, MASARU MORITA and YASUSHI TOH
    Anticancer Research February 2023, 43 (2) 893-901; DOI: https://doi.org/10.21873/anticanres.16232
  • You have access
    The Prognostic Implications of Perioperative Serum Cholesterol Levels in Patients With Gastric Cancer
    ATSUSHI YAMAMOTO, KATSUTOSHI SHODA, YOSHIHIKO KAWAGUCHI, HIDENORI AKAIKE, SHINJI FURUYA, KENSUKE SHIRAISHI, KAZUYOSHI HIRAYAMA, RYO SAITO, NAOKI ASHIZAWA, KOICHI TAKIGUCHI, NAOHIRO HOSOMURA, HIDETAKE AMEMIYA, HIROMICHI KAWAIDA, HIROSHI KONO and DAISUKE ICHIKAWA
    Anticancer Research February 2023, 43 (2) 903-909; DOI: https://doi.org/10.21873/anticanres.16233
  • You have access
    Outcomes of the Sequential Treatment of Unresectable Hepatocellular Carcinoma Using Lenvatinib
    DAISUKE NAKAGAWA, SHOHEI KOMATSU, YOSHIHIKO YANO, MASAHIRO KIDO, KAORI KURAMITSU, ATSUSHI YAMAMOTO, SATOSHI OMIYA, YUHI SHIMURA, TADAHIRO GOTO, HIROAKI YANAGIMOTO, HIROCHIKA TOYAMA, YOSHIHIDE UEDA, YUZO KODAMA and TAKUMI FUKUMOTO
    Anticancer Research February 2023, 43 (2) 911-918; DOI: https://doi.org/10.21873/anticanres.16234
  • You have access
    Real-world Data on the Incidence of Coronavirus Disease (COVID-19) in Patients With Advanced Thoracic Cancer During the Early Phase of the Pandemic in Japan
    AKITO FUKUDA, TATSUYA YOSHIDA, SHIGEHIRO YAGISHITA, MIKA SHIOTSUKA, OSAMU KOBAYASHI, SATOSHI IWATA, HITOMI UMEGUCHI, MASATOSHI YANAGIDA, YASUHIRO IRINO, KEN MASUDA, YUKI SHINNO, YUSUKE OKUMA, YASUSHI GOTO, HIDEHITO HORINOUCHI, AKINOBU HAMADA, NOBORU YAMAMOTO and YUICHIRO OHE
    Anticancer Research February 2023, 43 (2) 919-926; DOI: https://doi.org/10.21873/anticanres.16235
  • You have access
    Examining the Efficacy of Nivolumab for Gastric Cancer Focusing on Using an Inflammation-based Prognostic Score: A Multicenter Retrospective Study
    NOBUHIRO NAKAZAWA, MAKOTO SOHDA, KOHEI TATENO, TAKAYOSHI WATANABE, AKIHARU KIMURA, NORIMICHI KOGURE, HISASHI HOSAKA, ATSUSHI NAGANUMA, MASANORI SEKIGUCHI, KANA SAITO, KYOICHI OGATA, AKIHIKO SANO, MAKOTO SAKAI, HIROOMI OGAWA, KEN SHIRABE and HIROSHI SAEKI
    Anticancer Research February 2023, 43 (2) 927-934; DOI: https://doi.org/10.21873/anticanres.16236
  • You have access
    Cumulative Incidence of Thromboembolism and Prognostic Impact of Stroke in BRAF V600E-mutant Non-small-cell Lung Cancer
    SHO YAMADA, AKIMASA SEKINE, ERI HAGIWARA, YOKO ONODERA, ERINA TABATA, SATOSHI IKEDA, HIDEYA KITAMURA, TOMOHISA BABA, SHIGERU KOMATSU and TAKASHI OGURA
    Anticancer Research February 2023, 43 (2) 935-938; DOI: https://doi.org/10.21873/anticanres.16237
  • You have access
    Clear-cell Variant of Mucoepidermoid Carcinoma Presenting as a Palatal Mass in a 10-Year-old Boy
    SOPHIA H. HAN, THOMAS R. O’TOOLE, REID G. MEYER, KATHERINE B. GEIERSBACH, MOHAMMED N. ISLAM, LIRONG CHENG and JINPING LAI
    Anticancer Research February 2023, 43 (2) 939-942; DOI: https://doi.org/10.21873/anticanres.16238
  • You have access
    Conversion Surgery After Atezolizumab Plus Bevacizumab for Primary and Peritoneal Metastasis After Hepatocellular Carcinoma Rupture
    TATSUNORI MIYATA, KAZUHIRO SUGI, TAICHI HORINO, ASUKA ONO, YOSHIYUKI TAGAYASU, DAICHI NOMOTO, MITSUHIRO INOUE, TAKAO MIZUMOTO, TATSUO KUBOTA, ERIKO YANAGIDA, TOSHIHIKO MURAYAMA, NOBUTOMO MIYANARI and HIDEO BABA
    Anticancer Research February 2023, 43 (2) 943-947; DOI: https://doi.org/10.21873/anticanres.16239

Book Reviews

  • Open Access
    Book Reviews
    Anticancer Research February 2023, 43 (2) 949-950;
Back to top
Previous

In this issue

Anticancer Research: 43 (2)
Anticancer Research
Vol. 43, Issue 2
February 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • Treatment of Human Pancreatic Cancers Following Local and Systemic Administration of Oncolytic Adenovirus Serotype 35
  • Contrast-enhanced Ultrasound Using Intradermal Microbubble Sulfur Hexafluoride for Identification of Sentinel Lymph Nodes During Breast Cancer Surgery: A Clinical Trial
  • Ki67 and E-cadherin Are Independent Predictors of Long-term Survival in Endometrial Carcinoma
  • Real-World Data on Olaparib in Relapsed BRCA-mutated Ovarian Cancer: A Multicenter GINECO RETROLA Cohort Study
  • Refined Diagnosis of Pleural Effusions by Immunocytochemistry of Cell Blocks
Sign up for alerts

Jump to

  • Reviews
  • Experimental Studies
  • Clinical Studies
  • Book Reviews
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire